-
公开(公告)号:US07803838B2
公开(公告)日:2010-09-28
申请号:US11141235
申请日:2005-05-31
申请人: Eric Davis , John O'Donnell , Peter Bottini
发明人: Eric Davis , John O'Donnell , Peter Bottini
IPC分类号: A61K31/352 , C07D311/04
CPC分类号: A61K31/35 , A61K31/353
摘要: Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other active agent, wherein the at least one other active agent is a cardiovascular agent.
摘要翻译: 奈比洛尔已被证明对心血管疾病如高血压,充血性心力衰竭,动脉僵硬和内皮功能障碍的治疗有益。 本发明的特征在于包含奈比洛尔和至少一种其它活性剂的药物组合物,其中所述至少一种其它活性剂是心血管药剂。
-
公开(公告)号:US20090215844A1
公开(公告)日:2009-08-27
申请号:US12366866
申请日:2009-02-06
申请人: Eric Davis , John O'Donnell , Peter Bottini
发明人: Eric Davis , John O'Donnell , Peter Bottini
IPC分类号: A61K31/353 , A61K31/401 , A61K31/41
CPC分类号: A61K31/35 , A61K31/353
摘要: Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other active agent, wherein the at least one other active agent is a cardiovascular agent.
-
公开(公告)号:US20090227646A1
公开(公告)日:2009-09-10
申请号:US12366931
申请日:2009-02-06
申请人: Eric Davis , John O'Donnell , Peter Bottini
发明人: Eric Davis , John O'Donnell , Peter Bottini
CPC分类号: A61K31/35 , A61K31/353
摘要: Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other active agent, wherein the at least one other active agent is a cardiovascular agent.
摘要翻译: 奈比洛尔已被证明对心血管疾病如高血压,充血性心力衰竭,动脉僵硬和内皮功能障碍的治疗有益。 本发明的特征在于包含奈比洛尔和至少一种其它活性剂的药物组合物,其中所述至少一种其它活性剂是心血管药剂。
-
公开(公告)号:US20050272810A1
公开(公告)日:2005-12-08
申请号:US11141235
申请日:2005-05-31
申请人: Eric Davis , John O'Donnell , Peter Bottini
发明人: Eric Davis , John O'Donnell , Peter Bottini
IPC分类号: A61K31/35 , A61K31/353
CPC分类号: A61K31/35 , A61K31/353
摘要: Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other active agent, wherein the at least one other active agent is a cardiovascular agent.
摘要翻译: 奈比洛尔已被证明对心血管疾病如高血压,充血性心力衰竭,动脉僵硬和内皮功能障碍的治疗有益。 本发明的特征在于包含奈比洛尔和至少一种其它活性剂的药物组合物,其中所述至少一种其它活性剂是心血管药剂。
-
-
-